ADME Study of [14C] Yiqibuvir in Healthy Male Subjects

Clinical trial NCT05998304 · COMPLETED

Trial details

NCT number: NCT05998304
Sponsor: Sunshine Lake Pharma Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Male Subjects

Start date: 2023-08-07
Primary completion: 2023-09-12
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.